The ABCG2/BCRP transporter and its variants – from structure to pathology

  • Balázs Sarkadi
    Institute of Enzymology Research Centre for Natural Sciences Budapest Hungary
  • László Homolya
    Institute of Enzymology Research Centre for Natural Sciences Budapest Hungary
  • Tamás Hegedűs
    Department of Biophysics and Radiation Biology Semmelweis University Budapest Hungary

説明

<jats:p>The ABCG2 protein has a key role in the transport of a wide range of structurally dissimilar endo‐ and xenobiotics in the human body, especially in the tissue barriers and the metabolizing or secreting organs. The human <jats:italic>ABCG2</jats:italic> gene harbors a high number of polymorphisms and mutations, which may significantly modulate its expression and function. Recent high‐resolution structural data, complemented with molecular dynamic simulations, may significantly help to understand intramolecular movements and substrate handling, as well as the effects of mutations on the membrane transporter function of ABCG2. As reviewed here, structural alterations may result not only in direct alterations in drug binding and transporter activity, but also in improper folding or problems in the carefully regulated process of trafficking, including vesicular transport, endocytosis, recycling, and degradation. Here, we also review the clinical importance of altered ABCG2 expression and function in general drug metabolism, cancer multidrug resistance, and impaired uric acid excretion, leading to gout.</jats:p>

収録刊行物

  • FEBS Letters

    FEBS Letters 594 (23), 4012-4034, 2020-10-16

    Wiley

被引用文献 (2)*注記

もっと見る

問題の指摘

ページトップへ